The JSE had its third day of gains on Tuesday as progress in creating a Covid-19 vaccine and the EU’s stimulus deal boosted appetite for riskier assets.
Markets rallied following reports that an experimental vaccine trial by Oxford University and British-Swedish pharmaceutical group AstraZeneca induced an immune response. Data showed that a vaccine trial by German BioNTech and US pharmaceutical firm Pfizer also showed positive results and that it is safe for humans.
Canada Canada Latest News, Canada Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
MARKET WRAP: JSE firms on ongoing stimulus talks‘The dollar was firmer against most currencies today with the exception of the euro as markets await the outcome of EU stimulus talks’
Source: BDliveSA - 🏆 12. / 63 Read more »
Source: eNCA - 🏆 49. / 51 Read more »
Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
Source: BDliveSA - 🏆 12. / 63 Read more »
WATCH: How lockdown has laid waste to the labour marketPrincipal investigator of the NIDS CRAM project Nic Spaull talks to Business Day TV about what their survey revealed.
Source: BDliveSA - 🏆 12. / 63 Read more »
Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
Source: BDliveSA - 🏆 12. / 63 Read more »